Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We have studied a patient with Marfan syndrome whose mutation was not detected by heteroduplex analysis. Primary cultured patient fibroblasts were metabolically labelled and found to secrete fibrillin-1 defectively when compared with an age-matched control. Sequencing of patient cDNA, isolated by reverse transcription-polymerase chain reaction of patient fibroblast RNA, detected a 33-bp insertion. The reading frame of the mutant allele was maintained and predicted the insertion of 11 amino acids at the beginning of calcium-binding epidermal growth factor-like domain 29. Direct sequencing of genomic DNA detected a heterozygous G+1-->A transversion in intron 46 of FBN1. The 11 amino acid insertion was the consequence of the usage of a cryptic splice site 33-bp downstream of the mutation. This is the first reported case of a splicing defect in FBN1 leading to the production of a full-length fibrillin-1 transcript containing a large amino acid insertion.

Original publication

DOI

10.1007/s004390100573

Type

Journal article

Journal

Hum Genet

Publication Date

10/2001

Volume

109

Pages

416 - 420

Keywords

Adult, Alternative Splicing, Amino Acid Sequence, Base Sequence, Cysteine, DNA Mutational Analysis, Exons, Fibrillin-1, Fibrillins, Fibroblasts, Heteroduplex Analysis, Humans, Male, Marfan Syndrome, Microfilament Proteins, Molecular Sequence Data, Mutagenesis, Insertional, RNA, Messenger, Reverse Transcriptase Polymerase Chain Reaction